UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000037747
Receipt number R000043048
Scientific Title The Real-World Clinical Benefits of Following Therapy after Trastuzumab Emtansine (T-DM1) for HER2-positive Metastatic Breast Cancer: A Multicentral Cohort Study(WJOG12519B)
Date of disclosure of the study information 2019/08/26
Last modified on 2021/02/18 13:11:16

No. Disposal Last modified on Item of update
1 Insert 2019/08/20 17:21:15
2 Update 2019/08/26 09:15:39 Recruitment status
Date of IRB
3 Update 2019/11/28 17:13:01 Recruitment status
4 Update 2021/02/18 13:11:16 Recruitment status